American International Group, Inc. Fate Therapeutics Inc Transaction History

American International Group, Inc.

$27.6 Billion
Q1 2024

A detailed history of American International Group, Inc. transactions in Fate Therapeutics Inc stock. As of the latest transaction made, American International Group, Inc. holds 41,767 shares of FATE stock, worth $134,489. This represents 0.0% of its overall portfolio holdings.

Number of Shares

41,767

Previous 42,126 0.85%

Holding current value

$134,489

Previous $157,000 94.9%

% of portfolio

0.0%

Previous 0.0%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$3.54 - $8.35 $1,270 - $2,997	-359 Reduced 0.85%	41,767 $306,000
Q4 2023 Feb 13, 2024	SELL	$1.65 - $3.94 $282 - $673	-171 Reduced 0.4%	42,126 $157,000
Q3 2023 Nov 13, 2023	BUY	$2.02 - $5.04 $3,040 - $7,585	1,505 Added 3.69%	42,297 $89,000
Q2 2023 Aug 04, 2023	BUY	$4.76 - $6.59 $3,203 - $4,435	673 Added 1.68%	40,792 $194,000
Q1 2023 May 12, 2023	BUY	$4.24 - $11.12 $3,383 - $8,873	798 Added 2.03%	40,119 $228,000

Q4 2022 Feb 10, 2023	SELL	$9.86 - $23.83 $1,400 - $3,383	-142 Reduced 0.36%	39,321 $396,000
Q3 2022 Nov 14, 2022	BUY	$21.04 - $36.06 $11,698 - $20,049	556 Added 1.43%	39,463 $884,000
Q2 2022 Aug 12, 2022	SELL	$17.78 - $42.39 $24,696 - $58,879	-1,389 Reduced 3.45%	38,907 $964,000
Q1 2022 May 13, 2022	SELL	$29.67 - $60.28 $84,114 - $170,893	-2,835 Reduced 6.57%	40,296 $1.56 Million
Q4 2021 Feb 11, 2022	SELL	$47.84 - $64.34 $61,761 - $83,062	-1,291 Reduced 2.91%	43,131 $2.52 Million
Q3 2021 Nov 12, 2021	SELL	$59.27 - $95.73 $29,990 - $48,439	-506 Reduced 1.13%	44,422 $2.63 Million
Q2 2021 Aug 13, 2021	SELL	$67.25 - $92.52 $103,296 - $142,110	-1,536 Reduced 3.31%	44,928 $3.9 Million
Q1 2021 May 07, 2021	BUY	$72.16 - $117.4 $177,946 - $289,508	2,466 Added 5.6%	46,464 $3.83 Million
Q4 2020 Feb 12, 2021	BUY	$38.09 - $100.95 $44,298 - $117,404	1,163 Added 2.72%	43,998 $4 Million
Q3 2020 Nov 04, 2020	BUY	$30.41 - $40.5 $137,726 - $183,424	4,529 Added 11.82%	42,835 $1.71 Million
Q2 2020 Aug 12, 2020	BUY	$20.21 - $35.23 $48,362 - $84,305	2,393 Added 6.66%	38,306 $1.31 Million
Q1 2020 May 04, 2020	SELL	$17.28 - $31.88 $35,856 - $66,151	-2,075 Reduced 5.46%	35,913 $798,000
Q4 2019 Feb 05, 2020	BUY	$13.39 - $20.73 $66,334 - $102,696	4,954 Added 15.0%	37,988 $743,000
Q3 2019 Nov 08, 2019	SELL	$15.47 - $22.5 $3,542 - $5,152	-229 Reduced 0.69%	33,034 $513,000
Q2 2019 Aug 13, 2019	SELL	$15.61 - $20.44 $84,543 - $110,703	-5,416 Reduced 14.0%	33,263 $675,000
Q1 2019 May 06, 2019	SELL	$13.15 - $18.71 $16,490 - $23,462	-1,254 Reduced 3.14%	38,679 $680,000
Q4 2018 Feb 13, 2019	BUY	$11.48 - $16.98 $75,951 - $112,339	6,616 Added 19.86%	39,933 $512,000
Q3 2018 Nov 09, 2018	BUY	$8.75 - $16.29 $8,251 - $15,361	943 Added 2.91%	33,317 $543,000
Q2 2018 Aug 08, 2018	BUY	$9.16 - $13.48 $13,831 - $20,354	1,510 Added 4.89%	32,374 $367,000
Q1 2018 May 07, 2018	BUY	$6.3 - $13.77 $32,640 - $71,342	5,181 Added 20.17%	30,864 $301,000
Q4 2017 Feb 09, 2018	BUY	$3.94 - $6.64 $480 - $810	122 Added 0.48%	25,683 $157,000
Q3 2017 Nov 09, 2017	BUY	$2.6 - $4.31 $66,458 - $110,167	25,561	25,561 $101,000

Others Institutions Holding FATE

# of Institutions

178

Shares Held

124M

Call Options Held

222K

Put Options Held

48.6K

View Full List

About FATE THERAPEUTICS INC

Ticker FATE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,000,304
Market Cap $312M
Description
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...

More about FATE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.

Account

American International Group, Inc. Fate Therapeutics Inc Transaction History